The decision to ditch the development of an existing facility in the Speke area of Liverpool comes at a time when Prime ...

AstraZeneca has scrapped plans to invest £450m in expanding a vaccine manufacturing plant in Liverpool, blaming a reduction in government support. The pharmaceutical giant has announced its decision ...

Pharmaceutical company AstraZeneca has cancelled a planned 450 million-pound investment in a vaccine manufacturing plant in ...

Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications ...

The pharmaceutical giant claimed the Labour Government failed to match Tory predecessor’s offer of help for its investment in ...

The pharmaceutical giant says the new Labour government has offered less investment than their Conservative predecessors.

AstraZeneca cancels £450m investment in UK after dispute over Government support - The pharmaceutical giant claimed the ...

-- AstraZeneca has shelved a plan to build a vaccine manufacturing plant in Speke, near Liverpool, valued at 450 million pounds ($558.7 million), after months of talks with British government ...

The move comes as the company faces ‘several challenges’ around the launching of medicines and timed out patents ...

Telegraph investigation has found ‘critical’ information was missing from early warnings about vaccine’s side effects ...